• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of jcmPermissionsJournals.ASM.orgJournalJCM ArticleJournal InfoAuthorsReviewers
J Clin Microbiol. May 1984; 19(5): 651–659.
PMCID: PMC271149

Antibody response to dengue-2 vaccine measured by two different radioimmunoassay methods.


Two different radioimmunoassays were used to detect virus-specific antibodies in sera from human volunteers inoculated with an attenuated dengue type 2 (DEN-2) vaccine (PR-159/S-1). An indirect radioimmunoassay required purified DEN-2 virions for optimal reactivity but was 10 to 500 times more sensitive than neutralization or hemagglutination inhibition tests. An antibody capture radioimmunoassay was able to utilize crude antigens from either DEN-infected mouse brains or Aedes albopictus cell culture supernatants. When the two radioimmunoassay techniques were compared, the indirect method appeared to be the best assay for immunoglobulin G (IgG), whereas the antibody capture method was more sensitive for IgM detection. Selected human sera were examined for IgG, IgM, and IgA responses by using both techniques at various intervals after immunization. Although there were differences in magnitude, yellow fever immune as well as flavivirus nonimmune volunteers responded to DEN-2 vaccination by demonstrating IgG, IgM, and IgA antibody responses. In the nonimmune group, the most prevalent immunoglobulin detected was IgM, whereas in the yellow fever immune group, the predominant post-DEN-2 vaccine immunoglobulin was IgG. The preponderance of DEN-2-specific neutralizing antibodies were associated with either IgM or IgG according to the immune status of the volunteer. All classes of immunoglobulins attained maximum levels between 21 and 60 days postvaccination. In the majority of volunteers, IgM responses were relatively transient and could not be detected 6 months after immunization, whereas IgG and IgA antibodies were still detectable after this period.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.3M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Bancroft WH, Top FH, Jr, Eckels KH, Anderson JH, Jr, McCown JM, Russell PK. Dengue-2 vaccine: virological, immunological, and clinical responses of six yellow fever-immune recipients. Infect Immun. 1981 Feb;31(2):698–703. [PMC free article] [PubMed]
  • Brandt WE, Buescher EL, Hetrick FM. Production and characterization of arbovirus antibody in mouse ascitic fluid. Am J Trop Med Hyg. 1967 May;16(3):339–347. [PubMed]
  • Burke DS, Nisalak A. Detection of Japanese encephalitis virus immunoglobulin M antibodies in serum by antibody capture radioimmunoassay. J Clin Microbiol. 1982 Mar;15(3):353–361. [PMC free article] [PubMed]
  • Burke DS, Nisalak A, Ussery MA. Antibody capture immunoassay detection of japanese encephalitis virus immunoglobulin m and g antibodies in cerebrospinal fluid. J Clin Microbiol. 1982 Dec;16(6):1034–1042. [PMC free article] [PubMed]
  • CLARKE DH, CASALS J. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am J Trop Med Hyg. 1958 Sep;7(5):561–573. [PubMed]
  • Eckels KH, Harrison VR, Summers PL, Russell PK. Dengue-2 vaccine: preparation from a small-plaque virus clone. Infect Immun. 1980 Jan;27(1):175–180. [PMC free article] [PubMed]
  • Edelman R, Nisalak A, Pariyanonda A, Udomsakdi S, Johnsen DO. Immunoglobulin response and viremia in dengue-vaccinated gibbons repeatedly challenged with Japanese encephalitis virus. Am J Epidemiol. 1973 Mar;97(3):208–218. [PubMed]
  • Elder EM, Brown A, Remington JS, Shonnard J, Naot Y. Microenzyme-linked immunosorbent assay for detection of immunoglobulin G and immunoglobulin M antibodies to Legionella pneumophila. J Clin Microbiol. 1983 Jan;17(1):112–121. [PMC free article] [PubMed]
  • Gentry MK, Henchal EA, McCown JM, Brandt WE, Dalrymple JM. Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies. Am J Trop Med Hyg. 1982 May;31(3 Pt 1):548–555. [PubMed]
  • HAMMON WM, RUDNICK A, SATHER GE. Viruses associated with epidemic hemorrhagic fevers of the Philippines and Thailand. Science. 1960 Apr 15;131(3407):1102–1103. [PubMed]
  • Hornsleth A, Leerhoy J, Grauballe P, Spanggaard H. Persistence of rubellavirus-specific immunoglobulin M and immunoglobulin A antibodies: investigation of successive serum samples with lowered immunoglobulin G concentration. Infect Immun. 1975 Apr;11(4):804–808. [PMC free article] [PubMed]
  • HOTTA S. Experiments of active immunization against dengue with mouse-passaged unmodified virus. Acta Trop. 1954;11(2):97–104. [PubMed]
  • Inouye S, Matsuno S, Kono R, Sangkawibha N, Thongcharoen P. Hemagglutination-inhibiting immunoglobulin A antibody in the serum of patients with dengue hemorrhagic fever. Jpn J Med Sci Biol. 1980 Jun;33(3):181–184. [PubMed]
  • Ishii K, Matsunaga Y, Kono R. Immunoglobulins produced in response to Japanese encephalitis virus infections of man. J Immunol. 1968 Oct;101(4):770–775. [PubMed]
  • Monath TP. Neutralizing antibody responses in the major immunoglobulin classes to yellow fever 17D vaccination of humans. Am J Epidemiol. 1971 Feb;93(2):122–129. [PubMed]
  • Rosenthal JD, Hayashi K, Notkins AL. Rapid micro-radioimmunoassay for the measurement of antiviral antibody. J Immunol. 1972 Jul;109(1):171–173. [PubMed]
  • Russell PK, Nisalak A, Sukhavachana P, Vivona S. A plaque reduction test for dengue virus neutralizing antibodies. J Immunol. 1967 Aug;99(2):285–290. [PubMed]
  • Sabin AB, Schlesinger RW. PRODUCTION OF IMMUNITY TO DENGUE WITH VIRUS MODIFIED BY PROPAGATION IN MICE. Science. 1945 Jun 22;101(2634):640–642. [PubMed]
  • DORRANCE WR, FRANKEL JW, GORDON I, PATTERSON PR, SCHLESINGER RW, WINTER JW. Clinical and serologic response of man to immunization with attenuated dengue and yellow fever viruses. J Immunol. 1956 Nov;77(5):352–364. [PubMed]
  • Scott RM, Eckels KH, Bancroft WH, Summers PL, McCown JM, Anderson JH, Russell PK. Dengue 2 vaccine: dose response in volunteers in relation to yellow fever immune status. J Infect Dis. 1983 Dec;148(6):1055–1060. [PubMed]
  • Westaway EG. Greater specificity of 19S than 7S antibodies on haemagglutination-inhibition tests with closely related group B arboviruses. Nature. 1968 Jul 6;219(5149):78–79. [PubMed]
  • Westaway EG, Della-Porta AJ, Reedman BM. Specificity of IgM and IgG antibodies after challenge with antigenically related togaviruses. J Immunol. 1974 Feb;112(2):656–663. [PubMed]
  • Zollinger WD, Dalrymple JM, Artenstein MS. Analysis of parameters affecting the solid phase radioimmunoassay quantitation of antibody to meningococcal antigens. J Immunol. 1976 Nov;117(5 PT2):1788–1798. [PubMed]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...